Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03481023Not ApplicableCompleted

Esophageal Cooling in Radiofrequency Cardiac Ablation

Role: lead

NCT03817606Not ApplicableTerminated

A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant

Role: lead

NCT05068154Unknown

Myovista vs NT Pro-BNP Heart Failure Referral Tool

Role: collaborator

NCT03885726Not ApplicableCompleted

HVNI Ambulation Feasibility Study

Role: collaborator

All 4 trials loaded